CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...